Literature DB >> 26598308

Why Stop Now? Extended and Continuous Regimens of Combined Hormonal Contraceptive Methods.

Lyndsey S Benson1, Elizabeth A Micks2.   

Abstract

Combined hormonal contraceptives (CHCs) have traditionally been prescribed in 28-day cycles, with 21 days of active hormones followed by a 7-day hormone-free interval. Extended and continuous CHC regimens, defined as regimens with greater than 28 days of active hormones, offer many benefits, including a decrease in estrogen-withdrawal symptoms and likely greater efficacy because of more reliable ovulation suppression. Bleeding profiles are favorable, and unscheduled bleeding decreases over time with these regimens. Extended and continuous regimens of combined oral contraceptives and the contraceptive vaginal ring are safe and have high user acceptability and satisfaction. However, despite numerous benefits, extended and continuous CHC regimens are underused.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bleeding profile with contraception; Combined hormonal contraception; Combined oral contraceptive pills; Continuous contraceptive use; Contraceptive transdermal patch; Contraceptive vaginal ring; Extended contraceptive use; Ovulation suppression

Mesh:

Substances:

Year:  2015        PMID: 26598308     DOI: 10.1016/j.ogc.2015.07.009

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  4 in total

1.  Migraine diagnosis and treatment: A knowledge and needs assessment of women's healthcare providers.

Authors:  Allison M S Verhaak; Anne Williamson; Amy Johnson; Andrea Murphy; Matthew Saidel; Abigail L Chua; Mia Minen; Brian M Grosberg
Journal:  Headache       Date:  2020-12-30       Impact factor: 5.887

2.  Treatment preferences among Japanese women with dysmenorrhea: results from a discrete choice experiment study.

Authors:  Sayako Akiyama; Amir Goren; Enrique Basurto; Tetsushi Komori; Tasuku Harada
Journal:  Patient Prefer Adherence       Date:  2018-08-31       Impact factor: 2.711

Review 3.  CE: An Evidence-Based Update on Contraception.

Authors:  Laura E Britton; Amy Alspaugh; Madelyne Z Greene; Monica R McLemore
Journal:  Am J Nurs       Date:  2020-02       Impact factor: 2.577

Review 4.  Screening and Prevention for High-Grade Serous Carcinoma of the Ovary Based on Carcinogenesis-Fallopian Tube- and Ovarian-Derived Tumors and Incessant Retrograde Bleeding.

Authors:  Isao Otsuka; Takuto Matsuura
Journal:  Diagnostics (Basel)       Date:  2020-02-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.